Regional Analysis
Global Drug Abuse Treatment Market- Regional Insights
- North America is expected to be the largest market for drug abuse treatment during the forecast period, accounting for over 40.5% of the market share in 2023. The market growth in North America is due to increasing product launch by market players in the region. For instance, in May 2020, Hikma Pharmaceuticals PLC. a pharmaceutical company launched Buprenorphine Hydrochloride Injection, 0.3mg/mL, the generic version of Buprenex in the U.S.
- Europe is expected to be the second-largest market for drug abuse treatment, accounting for over 32.2% of the market share in 2023. The market growth is due to rising healthcare expenditure, stringent regulations, and increasing focus on patient safety and care quality in the region.
- Asia Pacific is expected to be the fastest-growing market for drug abuse treatment, with a CAGR of over 7.3% during the forecast period. The market growth in Asia Pacific is due to the improving healthcare IT infrastructure, growing medical tourism, and increasing focus on value-based care in the region.
- North America: U.S. and Canada
- Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
- Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
- Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
- Middle East: GCC Countries, Israel, and Rest of Middle East
- Africa: South Africa, North Africa, and Central Africa
U.S.: 
U.K. : 
India : 
